Nonalcoholic Steatohepatitis (NASH) is increasingly being recognized as a silent but severe threat to global health. Often overlooked in public health discussions, NASH—a progressive form of nonalcoholic fatty liver disease (NAFLD)—involves liver inflammation and damage caused by fat accumulation. Without intervention, it can lead to cirrhosis, liver failure, and liver cancer, placing a significant burden…
Nonalcoholic steatohepatitis (NASH) is an advanced form of nonalcoholic fatty liver disease (NAFLD), characterized by fat accumulation in the liver, along with inflammation and liver cell damage. Often called a silent epidemic, NASH progresses slowly, showing few or no symptoms until it reaches severe stages such as cirrhosis, liver failure, or hepatocellular carcinoma (HCC). With…
Non-alcoholic fatty liver disease (NAFLD) and its more severe form, non-alcoholic steatohepatitis (NASH), are two closely related liver conditions that have gained significant attention in recent years. As the prevalence of obesity and metabolic disorders rises globally, understanding the differences and overlaps between NAFLD and NASH is crucial for effective diagnosis, treatment, and management. 1.…